HLA-C and graft versus host disease: A shortcoming with the hu-BLT model is the development of what appears to be chronic xenogeneic graft versus host disease (cGvHD), in which any residual murine major histocompatibility complex (MHC) class I and II antigens are targeted by the human T cells after engraftment (117–120).